Stem Cells News and Research

RSS

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Researchers identify metabolic property of stem cells to survive in low-oxygen environments

UT Southwestern Medical Center researchers have identified unique metabolic properties that allow a specific type of stem cell in the body to survive and replicate in low-oxygen environments.

3 Sep 2010

Study establishes critical roles for cancer-causing Myc gene in stem cell biology

Stem cells might be thought of as trunks in the tree of life. All multi-cellular organisms have them, and they can turn into a dazzling variety other cells-kidney, brain, heart or skin, for example. One class, pluripotent stem cells, has the capacity to turn into virtually any cell type in the body, making them a focal point in the development of cell therapies, the conquering of age-old diseases or even regrowing defective body parts.

3 Sep 2010

Two scientists behind suit to block stem-cell research funding speak with lawmakers

The Wall Street Journal: "The two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said Wednesday they were motivated by ethical objections to destroying human embryos for medical research. The scientists, James Sherley of Boston and Theresa Deisher of Seattle, had never met until this week, when they flew to Washington to confer with House and Senate aides and lobby against research using embryonic stem cells.

3 Sep 2010

Simple protocol for determining Gross Chromosomal Rearrangement mutation rates

A cell devotes a significant amount of effort to maintaining the stability of its genome, preventing the sorts of chromosomal rearrangements characteristic of many cancers. Assays that measure the rate of gross chromosomal rearrangements (GCRs) are needed in order to understand the individual genes and the different pathways that suppress genomic instability.

3 Sep 2010

Study demonstrates safety of cord blood stem cell transplantation protocol to treat neurological conditions

In a new peer-reviewed article published by the Journal of Translational Medicine, scientists from Beike Biotechnology,China's leading stem cell research and regenerative medicine company, and Medistem, Inc.,reported positive safety data in 114 patients who were treated by doctors at Nanshan Affiliated Hospital of Guangdong Medical College (Shenzhen Nanshan Hospital) in Shenzhen using Beike's proprietary cord blood stem cell transplantation protocol.

3 Sep 2010

Research on motor neuron subtype may provide useful therapy for neuron diseases

Scientists have devised a method for coaxing mouse embryonic stem cells into forming a highly specific motor neuron subtype. The research, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, provides new insight into motor neuron differentiation and may prove useful for devising and testing future therapies for motor neuron diseases.

3 Sep 2010

Stem Cell Assurance announces $1M agreement with private funding source

Stem Cell Assurance, Inc., a leader in stem cell collection and storage services for personal applications ranging from breast augmentation and facial rejuvenation procedures to Stem Cellutrition skincare products, today announced a $1M agreement with a private funding source.

3 Sep 2010

Luminal intermediate cells impact basal-like breast cancer origin: Research

New research uncovers a case of mistaken identity that may have a significant impact on future breast cancer prevention and treatment strategies. The study, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, suggests that despite their "stem cell-like" characteristics, most aggressive breast tumors are not derived from normal mammary gland stem cells.

3 Sep 2010

Egg recall raises questions about FDA

The recent salmonella outbreak/egg recall is raising questions about whether the FDA is fulfilling its regulatory role, PBS' NewsHour reports. "For the past few years, it's been one food safety scare after another. There was E. coli-laced spinach, salmonella-tainted peppers. ... There have also been problems with drugs. The ingredients in a contaminated blood thinner came from China.

3 Sep 2010

Sigma-Aldrich Corporation announces global release of engineered mammalian cell lines

Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich Corporation, today announced the global release of a pioneering range of engineered mammalian cell lines.

2 Sep 2010

First Edition: September 2, 2010

Today's headlines include reports about a new study examining the impact of the health overhaul on the small business workforce.

2 Sep 2010

Cellerant Therapeutics signs contract with BARDA to develop CLT-008 therapy for ARS

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).

2 Sep 2010

First genetically engineered rat derived from rat ES cells developed with StemCells' technology

StemCells, Inc. announced today that its technology was recently used by independent researchers to achieve the first genetically engineered rat derived from rat embryonic stem (ES) cells. This breakthrough, published this month in the international peer-reviewed journal Nature, opens the door to the types of genetic manipulations previously only possible in mice, and paves the way for modeling a broader range of human diseases with the rat.

2 Sep 2010

'Sprouty' protein linked to regulation of bone mass and body fat

Here's good news for anyone trying to lose weight or has osteoporosis: Scientists from Maine are on the trail of a weight loss drug that may revolutionize how we treat these two conditions. In a new research report published in the September 2010 print issue of The FASEB Journal, the researchers describe a newly discovered protein, called "Sprouty," responsible for regulating body fat and bone mass. Then they manipulated how much of this protein was expressed in different groups of mice specially bred to have some human genes.

2 Sep 2010

Research on adult mammary stem cells may help to cure breast cancer

For the first time, researchers at Fred Hutchinson Cancer Research Center have identified and isolated adult mammary stem cells in mice. Long-term implications of this research may include the use of such cells to regenerate breast tissue, provide a better understanding of the role of adult stem cells in breast cancer development, and develop potential new targets for anti-cancer drugs.

2 Sep 2010

TriMark predicts regenerative medicine products will exceed $3 billion in 2010

TriMark Publications, LLC a global leader in the biotechnology, healthcare and life sciences publishing, cites in its newly published Regenerative Medicine Markets report that the global market for regenerative medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014.

2 Sep 2010

Pathology experts to evaluate medical, surgical breast cancer treatment at World Senologyc Congress

Spain will held the 16th World Senologyc Congress between the 20th and 22nd of October. This meeting will allow doctors to evaluate the progress achieved in medical and surgical breast cancer treatment and its future challenges. The best time to rebuilding breasts, how to preserve patients' fertility, the use of nodes self-transplant to treat lymphedema, the develop of new molecular targets and the use of stem cells will be some of the key issues to be treated during the congress.

31 Aug 2010

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Bioheart, Inc., The mission of the Cell Therapy Foundation is to improve public health through the support of effective adult stem cell research and education. The Foundation aims to promote basic and applied knowledge, processes and cell therapies.

31 Aug 2010

Advanced Cell Technology updates transdifferentiation plans to enhance regenerative medicine

Advanced Cell Technology, Inc. provides an update today on its plans to utilize its transdifferentiation platform to enhance regenerative medicine.

31 Aug 2010

Cell Therapy Foundation analysis calls for funding in medical research

Some of the most promising medical research conducted to treat diseases of the brain, heart, and circulatory system is moving too slowly to help millions of patients, according to the Cell Therapy Foundation, which advocates the use of adult stem cells to dramatically impact and improve the condition of patients who suffer from a variety of conditions.

31 Aug 2010

Stem Cells News and Research

Further Reading

Researchers identify metabolic property of stem cells to survive in low-oxygen environments

Study establishes critical roles for cancer-causing Myc gene in stem cell biology

Two scientists behind suit to block stem-cell research funding speak with lawmakers

Simple protocol for determining Gross Chromosomal Rearrangement mutation rates

Study demonstrates safety of cord blood stem cell transplantation protocol to treat neurological conditions

Research on motor neuron subtype may provide useful therapy for neuron diseases

Stem Cell Assurance announces $1M agreement with private funding source

Luminal intermediate cells impact basal-like breast cancer origin: Research

Egg recall raises questions about FDA

Sigma-Aldrich Corporation announces global release of engineered mammalian cell lines

First Edition: September 2, 2010

Cellerant Therapeutics signs contract with BARDA to develop CLT-008 therapy for ARS

First genetically engineered rat derived from rat ES cells developed with StemCells' technology

'Sprouty' protein linked to regulation of bone mass and body fat

Research on adult mammary stem cells may help to cure breast cancer

TriMark predicts regenerative medicine products will exceed $3 billion in 2010

Pathology experts to evaluate medical, surgical breast cancer treatment at World Senologyc Congress

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Advanced Cell Technology updates transdifferentiation plans to enhance regenerative medicine

Cell Therapy Foundation analysis calls for funding in medical research

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo